Low-molecular-weight heparin versus unfractionated heparin in acute ST-segment elevation myocardial infarction patients undergoing primary percutaneous coronary intervention with drug-eluting stents

American Heart Journal

Volumn 159, Issue 4, 2010, Pages

  Li, Yong Jian ^a,b   Rha, Seung Woon ^a   Chen, Kang Yin ^b   Poddar, Kanhaiya L ^a   Jin, Zhe ^b   Minami, Yoshiyasu ^a   Wang, Lin ^a   Dang, Qun ^b   Li, Guang Ping ^b   Ramasamy, Sureshkumar ^a   Park, Ji Young ^a   Choi, Chol Ung ^a   Kim, Jin Won ^a   Kim, Eung Ju ^a   Park, Chang Gyu ^a   Seo, Hong Seog ^a   Oh, Dong Joo ^a   Jeong, Myung Ho ^c   Ahn, Young Keun ^c   Hong, Taek Jong ^d   Park, Jong Seon ^e   Kim, Young Jo ^e   Hur, Seung Ho ^f   Seong, In Whan ^g   Chae, Jei Keon ^h   Cho, Myeong Chan ⁱ   Bae, Jang Ho ^j   Choi, Dong Hoon ^k   Jang, Yang Soo ^k   Chae, In Ho ^l   Kim, Hyo Soo ^m   Kim, Chong Jin ⁿ   Yoon, Jung Han ^o   Ahn, Tae Hoon ^p   Tahk, Seung Jea ^q   Chung, Wook Sung ^r   Seung, Ki Bae ^r   Park, Seung Jung ^s   more..

^a Korea University College of Medicine   (South Korea)

^b TIANJIN MEDICAL UNIVERSITY   (China)

^c Chonnam National University Medical School   (South Korea)

^d Pusan National University School of Medicine   (South Korea)

^e Young Nam University Hospital   (South Korea)

^f Keimyung University   (South Korea)

^g Chungnam National University College of Medicine   (South Korea)

^h Chonbuk National University Medical School   (South Korea)

ⁱ Chungbuk National University Hospital   (South Korea)

^j Konyang University College of Medicine   (South Korea)

^k Yonsei University College of Medicine   (South Korea)

^l Seoul National University Bundang Hospital   (South Korea)

^m Seoul National University Hospital   (South Korea)

ⁿ Kyung Hee University College of Medicine   (South Korea)

^o Wonju Severance Christian Hospital   (South Korea)

^p Cardiovascular Center   (South Korea)

^q Ajou University School of Medicine   (South Korea)

^r The Catholic University of Korea   (South Korea)

^s Asan Medical Center   (South Korea)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CILOSTAZOL; CLOPIDOGREL; ENOXAPARIN; HEPARIN;

ACUTE ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BLEEDING; CARDIOVASCULAR RISK; CLINICAL ASSESSMENT; CLINICAL TRIAL; CONFIDENCE INTERVAL; DRUG EFFICACY; DRUG ELUTING STENT; DRUG SAFETY; FEMALE; HEART DEATH; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; ST SEGMENT ELEVATION;

EID: 77950144610     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2009.12.041     Document Type: Article

References (20)

1. Daemen J., and Serruys P.W. Drug-eluting stent update 2007: part I. A survey of current and future generation drug-eluting stents: meaningful advances or more of the same?. Circulation 116 (2007) 316-328
2. Rao S.V., Shaw R.E., Brindis R.G., et al. On- versus off-label use of drug-eluting coronary stents in clinical practice (report from the American College of Cardiology National Cardiovascular Data Registry [NCDR]). Am J Cardiol 97 (2006) 1478-1481
3. Luscher T.F., Steffel J., Eberli F.R., et al. Drug-eluting stent and coronary thrombosis: biological mechanisms and clinical implications. Circulation 115 (2007) 1051-1058
4. Daemen J., Wenaweser P., Tsuchida K., et al. Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study. Lancet 369 (2007) 667-678
5. Gawaz M., Neumann F.J., Ott I., et al. Platelet function in acute myocardial infarction treated with direct angioplasty. Circulation 93 (1996) 229-237
6. Muller I., Seyfarth M., Rudiger S., et al. Effect of a high loading dose of clopidogrel on platelet function in patients undergoing coronary stent placement. Heart 85 (2001) 92-93
7. Antman E.M. The search for replacements for unfractionated heparin. Circulation 103 (2001) 2310-2314
8. Dumaine R., Borentain M., Bertel O., et al. Intravenous low-molecular-weight heparins compared with unfractionated heparin in percutaneous coronary intervention: quantitative review of randomized trials. Arch Intern Med 167 (2007) 2423-2430
9. Murphy S.A., Gibson C.M., Morrow D.A., et al. Efficacy and safety of the low-molecular weight heparin enoxaparin compared with unfractionated heparin across the acute coronary syndrome spectrum: a meta-analysis. Eur Heart J 28 (2007) 2077-2086
10. ADVANCE MI Investigators. Facilitated percutaneous coronary intervention for acute ST-segment elevation myocardial infarction: results from the prematurely terminated ADdressing the Value of facilitated ANgioplasty after Combination therapy or Eptifibatide monotherapy in acute Myocardial Infarction (ADVANCE MI) trial. Am Heart J 150 (2005) 116-122
11. Zeymer U., Gitt A., Zahn R., et al. Efficacy and safety of enoxaparin in combination with and without GP IIb/IIIa inhibitors in unselected patients with ST segment elevation myocardial infarction treated with primary percutaneous coronary intervention. EuroIntervention 4 (2009) 524-528
12. Kastrati A., Dibra A., Spaulding C., et al. Meta-analysis of randomized trials on drug-eluting stents vs. bare-metal stents in patients with acute myocardial infarction. Eur Heart J 28 (2007) 2706-2713
13. Antman E.M., Louwerenburg H.W., Baars H.F., et al. Enoxaparin as adjunctive antithrombin therapy for ST-elevation myocardial infarction: results of the ENTIRE-Thrombolysis in Myocardial Infarction (TIMI) 23 Trial. Circulation 105 (2002) 1642-1649
14. Antman E.M., Morrow D.A., McCabe C.H., et al. Enoxaparin versus unfractionated heparin with fibrinolysis for ST-elevation myocardial infarction. N Engl J Med 354 (2006) 1477-1488
15. Khoobiar S., Mejevoi N., Kaid K., et al. Primary percutaneous coronary intervention for ST-elevation myocardial infarction using an intravenous and subcutaneous enoxaparin low molecular weight heparin regimen. J Thromb Thrombolysis 26 (2008) 85-90
16. Zeymer U., Gitt A., Junger C., et al. Efficacy and safety of enoxaparin in unselected patients with ST-segment elevation myocardial infarction. Thromb Haemost 99 (2008) 150-154
17. Peters R.J., Joyner C., Bassand J.P., et al. The role of fondaparinux as an adjunct to thrombolytic therapy in acute myocardial infarction: a subgroup analysis of the OASIS-6 trial. Eur Heart J 29 (2008) 324-331
18. Buller C.E., Pate G.E., Armstrong P.W., et al. Catheter thrombosis during primary percutaneous coronary intervention for acute ST elevation myocardial infarction despite subcutaneous low-molecular-weight heparin, acetylsalicylic acid, clopidogrel and abciximab pretreatment. Can J Cardiol 22 (2006) 511-515
19. Montalescot G., Philippe F., Ankri A., et al. Early increase of von Willebrand factor predicts adverse outcome in unstable coronary artery disease: beneficial effects of enoxaparin. French Investigators of the ESSENCE Trial. Circulation 98 (1998) 294-299
20. Montalescot G., Collet J.P., Lison L., et al. Effects of various anticoagulant treatments on von Willebrand factor release in unstable angina. J Am Coll Cardiol 36 (2000) 110-114